StemCell Institute Inc.
StemCell Institute Inc. (7096.T) Stock Overview
Explore StemCell Institute Inc.’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
10.2B
P/E Ratio
26.65
EPS (TTM)
$37.71
ROE
0.14%
7096.T Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of StemCell Institute Inc. (7096.T) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 49.75, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $1061.03.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 26.65 and a market capitalization of 10.2B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.